For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Jounce Therapeutics, Inc.

USPTO Granted Patents = 10

EPO Patents = 2

Trademarks = 2

Forward Citations = 16

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Stephen Sazinsky (6 out of 6 patents)

Sriram Sathyanarayanan (4 out of 8 patents)

George Robert Mabry, Iii (3 out of 3 patents)

4. Kutlu Goksu Elpek (3 out of 4 patents)

5. Jennifer S Michaelson (3 out of 5 patents)

6. Heather B Cohen (2 out of 2 patents)

7. Lauren Pepper Mackenzie (2 out of 2 patents)

8. Donald Raymond Shaffer (2 out of 5 patents)

9. Jeffrey Yan-Fei Smith (2 out of 2 patents)

10. Christopher Harvey (2 out of 7 patents)

11. Heather Hirsch (1 out of 2 patents)

12. Deborah Law (1 out of 1 patent)

13. Amanda Elizabeth Hanson (1 out of 1 patent)

14. Martin Yu Fan (1 out of 1 patent)

15. Tatiana Novobrantseva (1 out of 30 patents)

10 patents: Sort by Forward Citations

1. 11905329 - Anti-PD-1 antibodies and uses thereof (2024-02-20),

2. 11384147 - Anti-PD-1 antibodies and uses thereof (2022-07-12),

3. 11359019 - Antibodies to LILRB2 (2022-06-14),

4. 11292840 - Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonist (2022-04-05),

5. 10968277 - Gene signatures for determining ICOS expression (2021-04-06),

6. 10723798 - Antibodies to LILRB2 (2020-07-28),

7. 10654929 - Antibodies to PD-1 and uses thereof (2020-05-19),

8. 10626176 - Methods of treating conditions with antibodies that bind B7-H4 (2020-04-21),

9. 10570203 - Antibodies to ICOS (2020-02-25),

10. 10023635 - Antibodies to ICOS (2018-07-17),

Jounce Therapeutics is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer through the development of novel, potential first-in-class immune therapies. The company's proprietary platform enables the design of highly specific and selective antibodies and T cell engagers that can modulate the immune system to recognize and attack cancer cells. Jounce Therapeutics is focused on advancing its pipeline of potential cancer immunotherapies to address unmet medical needs in multiple types of cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#203 in Cambridge, MA

#1,724 in Massachusetts

#29,006 in US

#54,324 in the World

Cambridge, MA, United States of America

Jounce Therapeutics, Inc.

Forward Citations = 16

21 inventors:

Stephen Sazinsky (6 out of 6 patents)

Sriram Sathyanarayanan (4 out of 8 patents)

George Robert Mabry, Iii (3 out of 3 patents)

4. Kutlu Goksu Elpek (3 out of 4 patents)

5. Jennifer S Michaelson (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…